• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Research Brief on 5-Chloro-2-iodoaniline (CAS: 6828-35-9): Recent Advances and Applications in Chemical Biology and Pharmaceutical Research

5-Chloro-2-iodoaniline (CAS: 6828-35-9) is a halogenated aniline derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a crucial intermediate in the synthesis of various bioactive molecules, including pharmaceuticals, agrochemicals, and materials science applications. Recent studies have explored its utility in cross-coupling reactions, particularly in palladium-catalyzed transformations, which are pivotal for constructing complex molecular architectures.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers demonstrated the efficacy of 5-Chloro-2-iodoaniline as a building block for the synthesis of novel kinase inhibitors. The compound's unique halogen substitution pattern allows for selective functionalization, enabling the development of targeted therapies for cancer and inflammatory diseases. The study highlighted its role in Suzuki-Miyaura cross-coupling reactions, which yielded high-affinity inhibitors of EGFR and VEGFR2 kinases, showcasing its potential in drug discovery pipelines.

Another significant advancement was reported in Organic Letters, where 5-Chloro-2-iodoaniline was employed in a copper-catalyzed amination reaction to produce arylamines with high regioselectivity. This methodology opens new avenues for the efficient synthesis of nitrogen-containing heterocycles, which are prevalent in many FDA-approved drugs. The researchers emphasized the compound's stability and reactivity under mild conditions, making it an attractive candidate for scalable pharmaceutical manufacturing.

From a toxicological perspective, recent investigations have focused on the environmental and metabolic fate of 5-Chloro-2-iodoaniline. A 2024 study in Chemical Research in Toxicology elucidated its degradation pathways in aqueous systems, revealing that advanced oxidation processes can effectively mineralize the compound without generating persistent toxic byproducts. These findings are critical for assessing the environmental impact of its industrial use and for developing greener synthetic protocols.

Looking ahead, the unique properties of 5-Chloro-2-iodoaniline position it as a key player in the development of next-generation pharmaceuticals and functional materials. Ongoing research is exploring its applications in photopharmacology, where its halogen atoms can be leveraged for light-controlled drug activation. As synthetic methodologies continue to evolve, this compound is expected to remain at the forefront of innovation in chemical biology and medicinal chemistry.

• 697-90-5(2,4-Dichloro-6-iodoaniline)
• 135050-44-1(3-Chloro-4-iodoaniline)
• 88149-53-5(Benzenamine, 4-chloro-2,6-diiodo-)
• 70237-25-1(3-Chloro-2-iodoaniline)
• 63069-48-7(4-Chloro-2-iodoaniline)
• 6781-33-5(2-iodo-5-chloroaniline hydrochloride)
• 128414-04-0(Benzenamine, 2-iodo-, hydrochloride)
• 84483-28-3(2-Chloro-6-iodoaniline)
• 83171-49-7(Benzenamine, 3-chloro-5-iodo-)
• 835595-11-4(Benzenamine, 3,4-dichloro-2-iodo-)